Studies of rare events have advanced scientific understanding of HIV prevention, treatment, and pathogenesis. While the definition of what is considered ‘rare’ is subjective, examples include individuals who: Remain free of HIV despite persistent high exposure; Acquire HIV in prevention studies & populations with low incidence; Exhibit extremes of disease progression: rapid disease progression, long-term survivors, elite suppressors; and/or Develop particular symptoms or disease conditions that might be the result of HIV infection, therapy, and/or comorbidities;
In this presentation, I will discuss how rare events impacts and motivates innovative methods in (1) study design options for observational and interventional investigations; (2) measurement, including methods for protecting against error and bias; and (3) causal and statistical inference, including the trend away from probabilistic-based inference and the rise of machine-learning techniques.